ZoIvian Vascular Technologies

Clinical Insight. Purposeful Engineering.

ZoIvian Vascular Technologies is a medical technology company developing a surgeon-tailorable synthetic coronary conduit that integrates surgical performance with targeted biomimetic design.

Our Purpose

We are developing a surgeon-tailorable conduit that combines coronary-specific mechanical and handling performance with targeted biomimetic functions. Our development program integrates these capabilities, with staged testing designed to establish performance.

Founder & CEO

Dr. Trevor C. Farnsworth, DMSc, MS, PA-C

A doctorally trained Physician Associate, Dr. Farnsworth brings 12 years and counting of clinical experience in cardiac surgery across private practice, major academic programs, and international practice in Europe.

His experience includes thousands of endoscopic saphenous vein and radial artery harvests, grounding ZoIvian’s development priorities in firsthand knowledge of conduit preparation and surgical usability.

He leads ZoIvian’s company strategy and clinical product direction, defining the program’s priorities for fabrication, engineering, testing, and biological evaluation.

Trevor is also an airplane pilot, with prior entrepreneurial experience through a company that transported organ transplant teams.

From Our Founder

Experience That Shapes The Design.

Across the teams and institutions I’ve worked with, I’ve seen substantial variation in how conduits are harvested, handled, and prepared. In my experience, obtaining the length of saphenous vein needed for a case could take longer than harvesting the internal mammary artery. Even with endoscopic techniques, bleeding, tissue injury, and harvest-site complications remained concerns. Those experiences made the practical demands of conduit preparation central to the problem I wanted to address.

That is the foundation of ZoIvian. We are developing a synthetic coronary conduit that brings surgical handling and targeted biomimetic function into one design. Preparation, suturing, and implantation are part of the design brief alongside the biological demands of a coronary graft.

Explore the clinical context

How We Work

ZoIvian leads the development program. Our collaboration model is capability-based: corporate–academic and industry work with clearly defined roles and scopes.

Contact ZoIvian